Ad is loading...
CDWCX
Price
$10.51
Change
-$0.07 (-0.66%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

CDWCX vs RNWFX

Header iconCDWCX vs RNWFX Comparison
Open Charts CDWCX vs RNWFXBanner chart's image
American Funds Dvlpg Wld Gr&Inc 529C
Price$10.51
Change-$0.07 (-0.66%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
CDWCX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CDWCX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDWCX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. CDWCX (1.82B). RNWFX pays higher dividends than CDWCX: RNWFX (1.51) vs CDWCX (0.96). CDWCX was incepted earlier than RNWFX: CDWCX (11 years) vs RNWFX (23 years). CDWCX is a more actively managed with annual turnover of: 37.00 vs. RNWFX (32.00). CDWCX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. CDWCX (8.14). RNWFX return over 5 years is better than : 17.17 vs. CDWCX (1.33).
CDWCXRNWFXCDWCX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD3.3767.09948%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B60.9B3%
Annual Yield % from dividends0.961.5164%
Returns for 1 year8.1411.5471%
Returns for 3 years-18.29-14.55126%
Returns for 5 years1.3317.178%
Returns for 10 years6.9941.0017%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics